Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Pinsky

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Statistics in Medicine|October 1, 1984
Experience with historical control studies in cancer immunotherapyC M Pinsky
The New England Journal of Medicine|September 11, 1986
Monoclonal antibodies: progress is slow but sureC M Pinsky
Cancer Treatment Reports|October 1, 1985
Applicability of phase I trial results in the design of phase II and III biological response modifier trialsC M Pinsky
Seminars in Oncology|June 1, 1986
Local administration of immunomodulatorsC M Pinsky
Journal of Surgical Oncology|September 1, 1985
Malignant melanoma appearing in a post-mastectomy lymphedematous arm: a novel association of double primary tumorsA H Bartal, C M Pinsky
Journal of Biological Response Modifiers|December 1, 1985
Polyribonucleotides for cancer therapy: summary and recommendations for further researchR B Herberman, C M Pinsky
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
Growth and differentiation controlG E Francis, C M Pinsky
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Growth and differentiation controlG E Francis, C M Pinsky
The Surgical Clinics of North America|December 1, 1981
Surgical adjuvant therapy for malignant melanomaC M Pinsky, H F Oettgen
The Medical Clinics of North America|May 1, 1976
Treatment of cancer with immunomodulatorsH F Oettgen, C M Pinsky, L Delmonte
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Statistics in Medicine|October 1, 1984
Experience with historical control studies in cancer immunotherapyC M Pinsky
The New England Journal of Medicine|September 11, 1986
Monoclonal antibodies: progress is slow but sureC M Pinsky
Cancer Treatment Reports|October 1, 1985
Applicability of phase I trial results in the design of phase II and III biological response modifier trialsC M Pinsky
Seminars in Oncology|June 1, 1986
Local administration of immunomodulatorsC M Pinsky
Journal of Surgical Oncology|September 1, 1985
Malignant melanoma appearing in a post-mastectomy lymphedematous arm: a novel association of double primary tumorsA H Bartal, C M Pinsky
Journal of Biological Response Modifiers|December 1, 1985
Polyribonucleotides for cancer therapy: summary and recommendations for further researchR B Herberman, C M Pinsky
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
Growth and differentiation controlG E Francis, C M Pinsky
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Growth and differentiation controlG E Francis, C M Pinsky
The Surgical Clinics of North America|December 1, 1981
Surgical adjuvant therapy for malignant melanomaC M Pinsky, H F Oettgen
The Medical Clinics of North America|May 1, 1976
Treatment of cancer with immunomodulatorsH F Oettgen, C M Pinsky, L Delmonte
Pageof 7